Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

1.8K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.8K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1.3K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.3K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

768
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
768
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.8K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.8K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

824
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
824
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing a Roadmap for a Competency-Based Point-of-Care Ultrasound Education Program.

The journal of education in perioperative medicine : JEPM·2025
Same author

Unrecognized Patent Foramen Ovale in Patient With Sinus Venosus-Type Atrial Septal Defect With Partial Anomalous Pulmonary Venous Return.

A&A practice·2023
Same author

Learning fiberoptic intubation on a simple model transfers to the O.R.

Canadian journal of anaesthesia = Journal canadien d'anesthesie·2016
Same author

Intraoperative transesophageal echocardiography to evaluate acute cessation of venous inflow during cardiopulmonary bypass.

A & A case reports·2015
Same author

Overcoming Challenges in the Management of Critical Events During Cardiopulmonary Bypass.

Seminars in cardiothoracic and vascular anesthesia·2014
Same author

Use of a transesophageal echocardiographic probe as a surface probe for evaluating the size, position, and patency of the internal jugular veins.

Journal of cardiothoracic and vascular anesthesia·2009

Related Experiment Video

Updated: May 4, 2026

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

2.8K

Acute and chronic respiratory failure.

Sabin Oana1, Jayanta Mukherji1

  • 1Department of Anesthesiology, Loyola University Medical Center, Maywood, IL, USA.

Handbook of Clinical Neurology
|December 25, 2013
PubMed
Summary

Neuromuscular diseases (NMDs) can cause respiratory failure (RF), requiring treatment that progresses from minimal support to mechanical ventilation (MV). Comprehensive care plans must align with patient preferences and current evidence-based guidelines.

Keywords:
Respiratory failureglossopharyngeal breathingmechanical ventilationnoninvasive ventilationsecretionssleep apneatracheostomyweaning

More Related Videos

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation
07:40

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation

Published on: August 30, 2019

10.0K
Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

3.1K

Related Experiment Videos

Last Updated: May 4, 2026

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

2.8K
A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation
07:40

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation

Published on: August 30, 2019

10.0K
Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

3.1K

Area of Science:

  • Neurology
  • Pulmonology
  • Critical Care Medicine

Background:

  • Respiratory failure (RF) is a significant complication of numerous neuromuscular diseases (NMDs).
  • The clinical presentation of RF in NMDs varies widely, ranging from subtle to overt symptoms.
  • Understanding the pathophysiology, diagnosis, and treatment of both NMDs and RF is crucial for managing these patients.

Purpose of the Study:

  • To outline the principles of managing respiratory failure in patients with neuromuscular diseases.
  • To emphasize the importance of evidence-based recommendations in diagnosis and treatment.
  • To highlight the need for personalized treatment plans that consider disease progression and patient autonomy.

Main Methods:

  • Review of current evidence-based recommendations for managing RF in NMDs.
  • Discussion of the pathophysiological principles underlying RF in NMDs.
  • Exploration of diagnostic approaches and treatment strategies, including respiratory support.

Main Results:

  • Treatment strategies for RF in NMDs are tailored to disease progression.
  • Interventions range from non-invasive respiratory support to mechanical ventilation (MV).
  • A multidisciplinary approach is essential for comprehensive patient care.

Conclusions:

  • Effective management of RF in NMDs requires adherence to the latest evidence-based guidelines.
  • Treatment plans must be individualized, considering the natural progression of the disease.
  • Incorporating patient wishes into the comprehensive care plan is paramount for optimal outcomes.